뒤로
Jiangsu Recbio Technology Co Ltd(02179.HK) 가격
02179.HK 주가 차트
RECBIO-B (02179.HK)
Jiangsu Recbio Technology Co Ltd
HK$4.5
0%
$0
장 종료: Feb 16, 12:00:00 HKT
주요 통계
이전 종가
$4.37
시가
$4.5
일일 범위
$4.5 - $4.5
52주 범위
$3.4 - $9.8
거래량
--
평균 거래량
32.8K
EPS(TTM)
-1.51
배당수익률
--
시가총액
$1.4B
RECBIO-B란 무엇인가요?
Jiangsu Recbio Technology Co., Ltd. engages in the research and development of vaccines. The company is headquartered in Taizhou, Jiangsu and currently employs 507 full-time employees. The company went IPO on 2022-03-31. The firm is still in the research and development stage. The firm's vaccine pipeline includes recombinant human papillomavirus (HPV) 9-valent vaccine, novel adjuvanted recombinant HPV 9-valent vaccine, recombinant HPV bivalent (Types 16/18) vaccine, recombinant HPV bivalent (Types 6/11) vaccine, novel adjuvanted recombinant HPV quadrivalent vaccine, novel adjuvanted recombinant shingles vaccine, novel adjuvanted recombinant respiratory syncytial virus vaccine, recombinant metapneumovirus vaccine, recombinant human cytomegalovirus vaccine, recombinant bicomponent COVID-19 vaccine, recombinant hepatitis B virus vaccine, and others.